| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Revenue | $729.6M | +12.5% |
| Cost of Revenue | $335.8M | +27.9% |
| Gross Profit | $393.8M | +2.1% |
| R&D Expense | $182.2M | +22.6% |
| SG&A Expense | $137.9M | +6.2% |
| Operating Income | $73.7M | -31.4% |
| Interest Expense | $5.1M | -58.5% |
| Pre-tax Income | $91.5M | -20.5% |
| Income Tax | $14.7M |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.8M | -15.6% |
| Short-term Investments | $435.1M | +27.7% |
| Accounts Receivable | $105.7M | +15.8% |
| Inventory | $194.5M | +42.7% |
| Current Assets | $903.1M | +18.6% |
| Total Assets | $1.76B | +13.0% |
| Current Liabilities | $108.2M | +29.5% |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $162.6M | -2.6% |
| Capital Expenditures | $22.4M | -9.1% |
| Investing Cash Flow | -$181.1M | -598.4% |
| Financing Cash Flow | -$9.1M | +93.9% |
| Free Cash Flow | $140.2M | -1.4% |
| -37.8% |
| Net Income | $76.9M | -16.1% |
| EPS (Basic) | $1.07 | -17.1% |
| EPS (Diluted) | $1.04 | -18.8% |
| Long-term Debt |
| $448.3M |
| +0.3% |
| Total Liabilities | $629.3M | +3.9% |
| Stockholders' Equity | $1.13B | +18.9% |